Rabia Gurses Ozden, M.D.

Rabia Gurses Ozden, M.D.

Chief Medical OfficeratOcular Therapeutix· In proxies 2022–2023

Pay in FY2023-1% from the year before · Ocular Therapeutix stock +58.7% the same year

Rabia Gurses Ozden, M.D. was paid $1.5M in FY2023 (Dec), down 1%. Ocular Therapeutix stock rose 58.7% that year.

Pay$100 in the stock at the end of FY21 → $64
Pay is from the Summary Compensation Table of each Ocular Therapeutix proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ocular TherapeutixPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role +6%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?